1. 24 Month Open Label Study of the Tolerability and Efficacy of Inotersen in TTR Amyloid Cardiomyopathy Patients - Full Text View - ClinicalTrials.gov [WWW Document], n.d.
2. Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy;Adams;BMC Neurol.,2017
3. Amyloidosis of the heart and kidney;Adrogue;Methodist Debakey Cardiovasc. J.,2022
4. Cardiac amyloidosis: pathogenesis, clinical context, diagnosis and management options;Alkhawam;Acta Cardiol.,2017
5. APOLLO-B: A Study to Evaluate Patisiran in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy) - Full Text View - ClinicalTrials.gov [WWW Document], n.d.